Thomas Campbell

10.9k citations

157 papers · 5.7k · 1 hit paper · h-index 42

Impact in

Virology top 0.2%
- HIV Research and Treatment
Emergency Medicine top 0.2%
- HIV-related health complications and treatments

Papers in

Infectious Diseases 70
- HIV/AIDS Research and Interventions 43
- HIV/AIDS drug development and treatment 31
- Parvovirus B19 Infection Studies 9
Virology 58
- HIV Research and Treatment 58

Co-authors: Samantha MaWhinney (20 shared papers)Kristine M. Erlandson (17 shared papers)Andrew P. Fontenot (9 shared papers)Brent E. Palmer (16 shared papers)Catherine M. Jankowski (10 shared papers)Wendy M. Kohrt (9 shared papers)Catherine Lozupone (10 shared papers)Amanda A. Allshouse (9 shared papers)
Journals: JAIDS Journal of Acquired Immune Deficiency Syndromes (13 papers)The Journal of Infectious Diseases (13 papers)AIDS (9 papers)Clinical Infectious Diseases (7 papers)PLoS ONE (7 papers)
Partner nations: United States Zimbabwe India

In The Last Decade

Thomas Campbell

149 papers receiving 5.6k citations

Thomas Campbell's Hit Papers

align trajectories log scale

Comparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers 2013 · 585 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 American Journal of Respiratory and Critical Care Medicine

Peers

Countries citing papers authored by Thomas Campbell

Since Specialization

Citations

This map shows the geographic impact of Thomas Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Campbell more than expected).

Fields of papers citing papers by Thomas Campbell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Campbell. The network helps show where Thomas Campbell may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Campbell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Campbell Line = papers co-authored together Thomas Campbell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Comparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers American Journal of Respiratory and Critical Care Medicine ·Alison Morris, James M. Beck, Patrick D. Schloss, Thomas Campbell, Kristina Crothers, Jeffrey L. Curtis, Sonia C. Flores, Andrew P. Fontenot, Elodie Ghedin, Laurence Huang, Kathleen Jablonski, Eric C. Kleerup, Susan V. Lynch, Erica Sodergren, Homer L. Twigg, Vincent B. Young, Christine M. Bassis, Arvind Venkataraman, Thomas M. Schmidt, George M. Weinstock Hit paper breakdown →	2013	585
2	Alterations in the Gut Microbiota Associated with HIV-1 Infection Cell Host & Microbe ·Catherine Lozupone, Marcella Li, Thomas Campbell, Sonia C. Flores, Derek J. Linderman, Matthew J. Gebert, Rob Knight, Andrew P. Fontenot, Brent E. Palmer	2013	342
3	Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial The Lancet ·Adriano Lazzarin, Thomas Campbell, Bonaventura Clotet, Margaret Johnson, Christine Katlama, A Moll, William Towner, Benoît Trottier, Monika Peeters, Johan Vingerhoets, Goedele De Smedt, Benny Baeten, Greet Beets, Rekha Sinha, Brian Woodfall	2007	315
4	Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment AIDS ·Jaroslaw Harezlak, Steven D. Buchthal, Michael D. Taylor, Giovanni Schifitto, Jianhui Zhong, Eric S. Daar, Jeffrey Alger, Elyse J. Singer, Thomas Campbell, Constantin T. Yiannoutsos, Ronald A. Cohen, Bradford Navia	2011	262
5	Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide Annals of Internal Medicine ·Katie R. Mollan, Marlene Smurzynski, Joseph J. Eron, Eric S. Daar, Thomas Campbell, Paul E. Sax, Roy M. Gulick, Lumine Na, Lauren R O'Keefe, Kevin R. Robertson, Camlin Tierney	2014	151
6	Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era Journal of NeuroVirology ·Ronald A. Cohen, Jaroslaw Harezlak, Giovanni Schifitto, George Hana, Uraina S. Clark, Assawin Gongvatana, Robert Paul, Michael J. Taylor, Paul M. Thompson, Jeffery R. Alger, Mark S. Brown, Jianhui Zhong, Thomas Campbell, Elyse J. Singer, Eric S. Daar, Deborah McMahon, Yuen Tso, Constantin T. Yiannoutsos, Bradford Navia	2010	148
7	Risk Factors for Falls in HIV-Infected Persons JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kristine M. Erlandson, Amanda A. Allshouse, Catherine M. Jankowski, Syki Duong, Samantha MaWhinney, Wendy M. Kohrt, Thomas Campbell	2012	134
8	Association of Functional Impairment with Inflammation and Immune Activation in HIV Type 1–Infected Adults Receiving Effective Antiretroviral Therapy The Journal of Infectious Diseases ·Kristine M. Erlandson, Amanda A. Allshouse, Catherine M. Jankowski, Eric Lee, Kevin M. Rufner, Brent E. Palmer, Cara C. Wilson, Samantha MaWhinney, Wendy M. Kohrt, Thomas Campbell	2013	132
9	HIV-induced alteration in gut microbiota Gut Microbes ·Catherine Lozupone, Matthew E. Rhodes, C. Preston Neff, Andrew P. Fontenot, Thomas Campbell, Brent E. Palmer	2014	119
10	Functional Impairment, Disability, and Frailty in Adults Aging with HIV-Infection Current HIV/AIDS Reports ·Kristine M. Erlandson, Jennifer A. Schrack, Catherine M. Jankowski, Todd T. Brown, Thomas Campbell	2014	114
11	An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men Microbiome ·Abigail Armstrong, Michael Shaffer, Nichole Nusbacher, Christine Griesmer, Suzanne Fiorillo, Jennifer M. Schneider, C. Preston Neff, Sam X. Li, Andrew P. Fontenot, Thomas Campbell, Brent E. Palmer, Catherine Lozupone	2018	112
12	Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage AIDS ·Thomas Campbell, Margaret Borok, Lovemore Gwanzura, Samantha MaWhinney, I. White, Buxton Ndemera, Ivy Gudza, Lisa Fitzpatrick, Robert T. Schooley	2000	111
13	Functional Impairment Is Associated With Low Bone and Muscle Mass Among Persons Aging With HIV Infection JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kristine M. Erlandson, Amanda A. Allshouse, Catherine M. Jankowski, Samantha MaWhinney, Wendy M. Kohrt, Thomas Campbell	2013	98
14	Antiviral Activity of Lamivudine in Salvage Therapy for Multidrug‐Resistant HIV‐1 Infection Clinical Infectious Diseases ·Thomas Campbell, Nancy S. Shulman, Steven C. Johnson, Andrew Zolopa, Russell K. Young, Lane R. Bushman, Courtney V. Fletcher, E. Randall Lanier, Thomas C. Merigan, Daniel R. Kuritzkes	2005	94
15	Comparison of Functional Status Instruments in HIV-Infected Adults on Effective Antiretroviral Therapy HIV Clinical Trials ·Kristine M. Erlandson, Amanda A. Allshouse, Catherine M. Jankowski, Syki Duong, Samantha MaWhinney, Wendy M. Kohrt, Thomas Campbell	2012	90
16	Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals EBioMedicine ·C. Preston Neff, Owen Krueger, Kathy Xiong, Sabrina J. Arif, Nichole Nusbacher, Jennifer M. Schneider, Annie W. Cunningham, Abigail Armstrong, Sam Li, Martin D. McCarter, Thomas Campbell, Catherine Lozupone, Brent E. Palmer	2018	81
17	Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma AIDS ·Emílio Letang, James Lewis, Mark Bower, Anisa Mosam, Margareth Borok, Thomas Campbell, Denise Naniche, Tom Newsom‐Davis, Fahmida Shaik, Suzanne Fiorillo, José M. Miró, David Schellenberg, Philippa Easterbrook	2013	81
18	HLA-DR⁺CD38⁺CD4⁺T Lymphocytes Have Elevated CCR5 Expression and Produce the Majority of R5-Tropic HIV-1 RNAInVivo Journal of Virology ·Amie L. Meditz, Michelle Haas, Joy M. Folkvord, Kelsey Melander, Russ Young, Martin D. McCarter, Samantha MaWhinney, Thomas Campbell, Yolanda Lie, Eoin Coakley, David N. Levy, Elizabeth Connick	2011	77
19	Characterization of HIV–HBV coinfection in a multinational HIV-infected cohort AIDS ·Chloe L. Thio, Laura Smeaton, Melissa Saulynas, Hyon S. Hwang, Shanmugam Saravan, Smita Kulkarni, James Hakim, Mulinda Nyirenda, Hussain Syed Iqbal, Umesh Lalloo, Anand S. Mehta, Kimberly Hollabaugh, Thomas Campbell, Shahin Lockman, Judith S. Currier	2012	75
20	SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2 PLoS Pathogens ·Katherine M. Littlefield, Renée O. Watson, Jennifer M. Schneider, C. Preston Neff, Eiko Yamada, Min Zhang, Thomas Campbell, Michael T. Falta, Sarah E. Jolley, Andrew P. Fontenot, Brent E. Palmer	2022	71

About Thomas Campbell

Thomas Campbell is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Epidemiology and Oncology, having authored 157 papers that have together received 5.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (58 papers), HIV-related health complications and treatments (46 papers), HIV/AIDS Research and Interventions (43 papers), HIV/AIDS drug development and treatment (31 papers), Viral-associated cancers and disorders (20 papers), Cytomegalovirus and herpesvirus research (18 papers), Gut microbiota and health (11 papers) and Parvovirus B19 Infection Studies (9 papers). The work is most often cited by research in Virology (2.0k citations), Emergency Medicine (1.7k citations), Infectious Diseases (2.6k citations), Biological Psychiatry (164 citations) and Epidemiology (1.3k citations). Thomas Campbell has collaborated with scholars based in United States, Zimbabwe and India. Frequent co-authors include Samantha MaWhinney, Kristine M. Erlandson, Andrew P. Fontenot, Brent E. Palmer, Catherine M. Jankowski, Wendy M. Kohrt, Catherine Lozupone, Amanda A. Allshouse, Sonia C. Flores and Eric S. Daar. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, The Journal of Infectious Diseases, AIDS, Clinical Infectious Diseases and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Thomas Campbell

Impact in

Papers in i

In The Last Decade

Thomas Campbell

Thomas Campbell's Hit Papers

Peers

Countries citing papers authored by Thomas Campbell

Fields of papers citing papers by Thomas Campbell

All Works

About Thomas Campbell

Explore authors with similar magnitude of impact

Papers in